Schott Pharma AG KGaA (WBO:1SXP) EV-to-EBITDA : 15.89 (As of May. 20, 2025)

Schott Pharma AG KGaA EV-to-EBITDA Chart

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial							19.74	26.04	18.19	17.83	15.14

Competitive Comparison of Schott Pharma AG KGaA's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's EV-to-EBITDA falls into.

Schott Pharma AG KGaA EV-to-EBITDA Calculation

Schott Pharma AG KGaA's EV-to-EBITDA for today is calculated as:

Schott Pharma AG KGaA's current Enterprise Value is €3,954.7 Mil.
Schott Pharma AG KGaA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €248.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA  (WBO:1SXP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Schott Pharma AG KGaA's PE Ratio (TTM) for today is calculated as:

Schott Pharma AG KGaA's share price for today is €27.00.
Schott Pharma AG KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.890.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Schott Pharma AG KGaA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description